Instil Bio, Inc. ( TIL) - Key Metrics
TIL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.63 | -$0.68 | -$0.68 |
| 2026Q1 | $0 | -$0.62 | -$0.20 | -$0.20 |
| 2025Q4 | $0 | -$1.21 | -$1.04 | -$1.04 |
| 2025Q3 | $0 | -$2.01 | -$1.56 | -$1.56 |
| 2025Q2 | $0 | -$3.24 | -$2.24 | -$2.24 |
TIL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.05 |
| 2026Q1 | 0% | -3.32 |
| 2025Q4 | 0% | -2.27 |
| 2025Q3 | 0% | -2.22 |
| 2025Q2 | 0% | -1.61 |
TIL
Price: $5.85
52 week price:
Earnings Per Share: -4.38 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 566200
Ebitda: -268970Market Capitalization: 49.0 million